August 21, 2013 @ Van de Kamp Innovation Center
Parking is free and adjacent to the Environmental Science and Technology High School (it has the LACCD Van de Kamp Innovation Center sign on it building)
Learn about the state of the bioscience industry in the Greater Los Angeles region. Join our distinguished speakers in the discourse about how our local companies can meet their talent needs to stay competitive
This SoCalBio Workforce Summit provides an opportunity to enhance the partnerships among bioscience industry executives, workforce development professionals, educators, and other state & local partners to help Southern California bioscience companies address their workforce issues and remain competitive.
Through creating partnerships, SoCalBio demonstrates its commitment to Southern California workers by ensuring that jobs paying good wages and providing benefits are available now and in the future. This Summit will be an opportunity to examine and expand those partnerships.
|8:30 am||Registration and continental breakfast|
|9:00 am||Welcoming remarks and introduction|
Morning keynote presentation:
"The Greater Los Angeles Bioscience Industry Cluster: Competitiveness, Market Dynamics and Workforce Development Trends,"
By Ryan Helwig, Sr. Economist, Battelle Technology Partnership Practice
Battelle, the world’s largest non-profit independent research and development organization, was retained by Los Angeles County to survey the Los Angeles bioscience industry cluster and develop a strategic plan to sustain its growth. Mr. Helwig is one of the key analysts working on this project. He will provide the final findings of the study and present the workforce development action steps recommended by Battelle's research team.
"New Knowledge and Skills in the Bioeconomy: Why Biomanufacturing Is Growing in Los Angeles"
"New Knowledge and Skills in the Bioeconomy: What Will Biomanufacturing Look Like in the Future?"
By Anthony Davies, PhD, Chief Scientific Officer, Capricor
Dr. Davies is a 20-year veteran of the biotech industry, 15 years of which have been in cell and gene therapy. He is an important addition to Capricor’s management team as Capricor proceeds with the ongoing enrollment of ALLSTAR, the Phase I/II study of Capricor's lead product candidate, cardiac-stem cell derived CAP-1002. Prior to Capricor, he served as Vice President, Product Development for Geron Corporation’s cell therapy programs. Prior to joining Geron, Dr. Davies had a successful career in process development and manufacturing at notable companies such as Serologicals Corporation, Velico Medical, Inc. (formerly ZymeQuest, Inc.) and Onyx Pharmaceuticals, Inc. While at Onyx, Dr. Davies was part of the development team for Nexavar, a kinase inhibitor with nearly a billion dollars in worldwide sales.
"Panel Discussion: Biomanufacturing Change Drivers"
Panelists will discuss how the bioeconomy's new norm requiring faster, cheaper and better products will change the face of biomanufacturing, the skills it requires and the geography of job creation.
|12:00 noon||Lunch break|
Luncheon Keynote Presentations:
"Talent Development Strategies and Transformational Change to Achieve Exceptional Results for your Company"
By Cathy Benko, Vice Chairman and Managing Principal, Deloitte LLP
Cathy Benko is a vice chairman and the chief talent officer for Deloitte, where she drives the organization’s strategy to attract and engage a highly skilled and diverse workforce for the firm. She is an authority on talent strategies and transformational change to achieve exceptional results. Previously, Benko served as a global e-business leader for Deloitte Consulting and subsequently led its high-technology industry sector as well as Deloitte’s award-winning Women’s Initiative. Among other distinctions, she has been named one of the Top 25 Consultants and a frontline leader by Consulting magazine. She is also the recipient of its inaugural Leadership award for Women Leaders in Consulting. Benko is a coauthor, with Molly Anderson, of The Corporate Lattice: Achieving High Performance in the Changing World of Work. She has also coauthored Mass Career Customization: Aligning the Workplace with Today’s Nontraditional Workforce with Anne Weisberg and Connecting the Dots: Aligning Projects with Objectives in Unpredictable Times with F. Warren McFarlan.
"How to Foster Development of Necessary Skills: Aligning up Education and Training for the Bioeconomy"
By Russell Read, PhD, Executive Director, c3bc
Russ Read has worked in senior positions in the pharmaceutical and biotechnology industry for over thirty years. His work with Burroughs Wellcome and subsequently Glaxo Wellcome led him to successive strategic marketing opportunities, including the launches of "bench to the bedside" antivirals such as acyclovir, AZT, 3TC and abacavir for the treatment of HIV. From mid 2001 until August 2004 he was the founding CEO & President of the Kucera Pharmaceutical Company. In January of 2005 he was appointed Executive Director of the National Center for the Biotechnology Workforce, based at Forsyth Tech Community College and now a funded center of NC BioNetwork. Russ has written multiple successful grant /loan /award applications to the US DOL, NSF, NIH, the North Carolina Biotechnology Center and the North Carolina Community College System's BioNetwork.
By Sonia Wallman,PhD, Executive Director NBC2
Dr. Wallman holds a PhD in Biology from Harvard University. Since 1994 she has been involved in biotechnology education and training. In that year she started a biotechnology technician-training program at the New Hampshire Community Technical College System's Pease International Tradeport Campus, that is modeled after an integrated biotechnology company (a Virtual Workplace). In order to set up an education and training program that models the industry, Dr. Wallman has worked with biotech companies in her state and nationally, and with agencies responsible for generating the Bioscience and Agricultural Biotechnology Skill Standards used by biotechnology educators. In 2002, Dr. Wallman was instrumental in obtaining funding for, designing, and building the new 5,000 square-foot New Hampshire Biotechnology Education and Training (NH BET) Center for Discovery Research and Biomanufacturing. The NH BET Center also functions as an incubator for small biotechnology companies. Dr. Wallman is the founder of the New Hampshire Biotechnology Council. She is a past member of the board of directors of the Council of Biotechnology Centers of the Biotechnology Industry Organization and is a member of the board of directors of the New England branch of the Society for Industrial Microbiology. In 1998, she became Northeast Region Director of Bio-Link, a National Science Foundation Advanced Technological Education (NSF ATE) Center for Biotechnology.
SoCalBio/c3bc: Training for Career Pathways Case Study
LAVC and Training for Biomanufacturing Technician Jobs
By Lennie Ciufo, Director, Job Training Program, Los Angeles Valley College
Next Steps: Making the Case for Targeting Medical Device Manufacturing Skills
By Ted Randolph, VP of Manufacturing, Second Sight Medical Products Corporation
Ted Randolph has held leadership positions in medical device manufacturing organizations for 20 years at companies including Boston Scientific and Ventritex (now part of St. Jude Medical). Now he is Vice President of Manufacturing for Second Sight Medical Products, Inc., where he was instrumental in the company receiving FDA approval for the Argus II Visual Prosthesis. He is currently preoccupied with ramping up the company's manufacturing of that product.
Panel Discussion on Medical Device Talent Nurturing
|4:00 pm||Concluding Remaks|
|4:10 pm||Summit Adjourns|